{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:30:49Z","timestamp":1785191449505,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["R01GM127558"],"award-info":[{"award-number":["R01GM127558"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015581","name":"Houston Methodist Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nano.2021.102417","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T03:32:04Z","timestamp":1624332724000},"page":"102417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Long-acting tunable release of amlodipine loaded PEG-PCL micelles for tailored treatment of chronic hypertension"],"prefix":"10.1016","volume":"37","author":[{"given":"Nicola","family":"Di Trani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruogu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixita I.","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine Ying Xuan","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Grattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.nano.2021.102417_bb0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00103-012-1493-4","article-title":"Kohortenstudie zu Risikofaktoren f\u00fcr Herz-Kreislauf-Krankheiten in einer urbanen \u00e4lteren ostdeutschen Allgemeinbev\u00f6lkerung (CARLA-Studie)","volume":"55","author":"Haerting","year":"2012","journal-title":"Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"},{"issue":"22","key":"10.1016\/j.nano.2021.102417_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000952","article-title":"Prevalence and incidence of hypertension in the general adult population: results of the CARLA-Cohort Study","volume":"94","author":"Lacruz","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.nano.2021.102417_bb0015","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","article-title":"2003 World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension","volume":"21","author":"Afridi","year":"2003","journal-title":"J Hypertens"},{"issue":"31","key":"10.1016\/j.nano.2021.102417_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7310","article-title":"Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy","volume":"7","author":"Law","year":"2003","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.nano.2021.102417_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Group DA-SCR. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nano.2021.102417_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cpdd.309","article-title":"Management of hypertension with a fixed-dose (single-pill) combination of bisoprolol and amlodipine","volume":"6","author":"Gottwald-Hostalek","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"1","key":"10.1016\/j.nano.2021.102417_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjmed.2003.08.027","article-title":"Calcium channel blockers: an update","volume":"116","author":"Eisenberg","year":"2004","journal-title":"Am J Med"},{"issue":"6709","key":"10.1016\/j.nano.2021.102417_bb0040","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bmj.299.6709.1187","article-title":"Calcium channel blockers in acute myocardial infarction and unstable angina: an overview","volume":"299","author":"Held","year":"1989","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.nano.2021.102417_bb0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of \u03b2 blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.nano.2021.102417_bb0050","unstructured":"Kane SP. The top 300 of 2021, ClinCalc DrugStats database, version 21.0. ClinCalc: https:\/\/clincalc.com\/DrugStats\/Top300Drugs.aspx. Updated November 19, 2020. Accessed November 30, 2020. [."},{"issue":"9","key":"10.1016\/j.nano.2021.102417_bb0055","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0002-9149(88)90647-9","article-title":"Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris","volume":"62","author":"Glasser","year":"1988","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.nano.2021.102417_bb0060","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure the CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"Jama-J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.nano.2021.102417_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000074241","article-title":"Amlodipine increases endothelial nitric oxide by dual mechanisms","volume":"70","author":"Berkels","year":"2004","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.nano.2021.102417_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ajh\/hpt202","article-title":"Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes","volume":"27","author":"Mason","year":"2014","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.nano.2021.102417_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000473","article-title":"Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes","volume":"3","author":"Fares","year":"2016","journal-title":"Open Heart"},{"issue":"7","key":"10.1016\/j.nano.2021.102417_bb0080","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res"},{"issue":"23","key":"10.1016\/j.nano.2021.102417_bb0085","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to improve medication adherence: a review","volume":"320","author":"Kini","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.nano.2021.102417_bb0090","series-title":"Medication non-adherence: an overlooked target for quality improvement interventions","author":"Franklin","year":"2020"},{"issue":"11","key":"10.1016\/j.nano.2021.102417_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-020-01400-3","article-title":"Medication non-adherence: a major cause of resistant hypertension","volume":"22","author":"Hamrahian","year":"2020","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"10.1016\/j.nano.2021.102417_bb0100","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.14193","article-title":"The medication adherence report scale: a measurement tool for eliciting patients\u2019 reports of nonadherence","volume":"86","author":"Chan","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.nano.2021.102417_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/hr.2015.142","article-title":"Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks","volume":"39","author":"Hermida","year":"2016","journal-title":"Hypertens Res"},{"issue":"12","key":"10.1016\/j.nano.2021.102417_bb0110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/17425255.2020.1825681","article-title":"Ingestion-time \u2014 relative to circadian rhythms \u2014 differences in the pharmacokinetics and pharmacodynamics of hypertension medications","volume":"16","author":"Hermida","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"10.1016\/j.nano.2021.102417_bb0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrneph.2013.79","article-title":"Chronotherapy improves blood pressure control and reduces vascular risk in CKD","volume":"9","author":"Hermida","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nano.2021.102417_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2017.11.024","article-title":"Circadian clock-mediated regulation of blood pressure","volume":"119","author":"Douma","year":"2018","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.nano.2021.102417_bb0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/10641963.2017.1281947","article-title":"S C. Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects","volume":"39","author":"Khodadoustan","year":"2017","journal-title":"Clin Exp Hypertens"},{"issue":"12","key":"10.1016\/j.nano.2021.102417_bb0130","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/HJH.0000000000000355","article-title":"Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13844 patients with hypertension","volume":"32","author":"Roush","year":"2014","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.nano.2021.102417_bb0135","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jconrel.2013.09.028","article-title":"Leveraging nanochannels for universal, zero-order drug delivery in vivo","volume":"172","author":"Ferrati","year":"2013","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.nano.2021.102417_bb0140","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/jsm.12897","article-title":"The nanochannel delivery system for constant testosterone replacement therapy","volume":"12","author":"Ferrati","year":"2015","journal-title":"J Sex Med"},{"issue":"9","key":"10.1016\/j.nano.2021.102417_bb0145","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1039\/D0LC00121J","article-title":"Electrostatically gated nanofluidic membrane for ultra-low power controlled drug delivery","volume":"20","author":"Di Trani","year":"2020","journal-title":"Lab Chip"},{"issue":"7","key":"10.1016\/j.nano.2021.102417_bb0150","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/pharmaceutics12070679","article-title":"Silicon nanofluidic membrane for electrostatic control of drugs and analytes elution","volume":"12","author":"Di Trani","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.nano.2021.102417_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jconrel.2018.08.010","article-title":"Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis","volume":"286","author":"Chua","year":"2018","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.nano.2021.102417_bb0160","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jbm.a.10152","article-title":"Plasma-enhanced chemical vapor deposited silicon carbide as an implantable dielectric coating","volume":"67","author":"Cogan","year":"2003","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"10.1016\/j.nano.2021.102417_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tsf.2007.04.050","article-title":"Characterization of a-SiCx: H thin films as an encapsulation material for integrated silicon based neural interface devices","volume":"516","author":"Hsu","year":"2007","journal-title":"Thin Solid Films"},{"issue":"1","key":"10.1016\/j.nano.2021.102417_bb0170","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/s41467-018-04133-8","article-title":"Unexpected behaviors in molecular transport through size-controlled nanochannels down to the ultra-nanoscale","volume":"9","author":"Bruno","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.nano.2021.102417_bb0175","doi-asserted-by":"crossref","DOI":"10.1088\/0957-0233\/25\/2\/027003","article-title":"Robotic UV\u2013vis apparatus for long-term characterization of drug release from nanochannels","volume":"25","author":"Geninatti","year":"2014","journal-title":"Measurement Science and Technology"},{"issue":"10","key":"10.1016\/j.nano.2021.102417_bb0180","doi-asserted-by":"crossref","first-page":"12246","DOI":"10.1021\/acsami.9b19182","article-title":"Finite-size charged species diffusion and pH change in nanochannels","volume":"12","author":"Di Trani","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"10.1016\/j.nano.2021.102417_bb0185","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1021\/ac1033648","article-title":"Device for rapid and agile measurement of diffusivity in micro- and nanochannels","volume":"83","author":"Grattoni","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.nano.2021.102417_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2018.06.035","article-title":"Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer","volume":"285","author":"Chua","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2021.102417_bb0195","doi-asserted-by":"crossref","unstructured":"Zorman CA, Eldridge A, Du JG, Johnston M, Dubnisheva A, Manley S, Fissell W, Fleischman A, Roy S, editors. Amorphous silicon carbide as a non-biofouling structural material for biomedical microdevices. Materials Science Forum; 2012: Trans Tech Publ.","DOI":"10.4028\/www.scientific.net\/MSF.717-720.537"},{"issue":"10","key":"10.1016\/j.nano.2021.102417_bb0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/pharmaceutics12100981","article-title":"Viral load reduction in SHIV-positive nonhuman primates via long-acting subcutaneous tenofovir alafenamide fumarate release from a nanofluidic implant","volume":"12","author":"Pons-Faudoa","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2021.102417_bb0205","series-title":"Hawkins T","author":"Pons-Faudoa","year":"2020"},{"key":"10.1016\/j.nano.2021.102417_bb0210","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2019.05.037","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis","volume":"306","author":"Pons-Faudoa","year":"2019","journal-title":"J Control Release"},{"issue":"63","key":"10.1016\/j.nano.2021.102417_bb0215","doi-asserted-by":"crossref","first-page":"58160","DOI":"10.1039\/C6RA06040D","article-title":"Biodegradable poly(ethylene glycol)\u2013poly(\u03b5-carprolactone) polymeric micelles with different tailored topological amphiphilies for doxorubicin (DOX) drug delivery","volume":"6","author":"Chen","year":"2016","journal-title":"RSC Adv"},{"issue":"1","key":"10.1016\/j.nano.2021.102417_bb0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/17425247.3.1.139","article-title":"Polymeric micelles for drug delivery","volume":"3","author":"Aliabadi","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"issue":"23","key":"10.1016\/j.nano.2021.102417_bb0225","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1039\/C7PY00646B","article-title":"A facile strategy for manipulating micellar size and morphology through intramolecular cross-linking of amphiphilic block copolymers","volume":"8","author":"Tanaka","year":"2017","journal-title":"Polymer chemistry"},{"issue":"2","key":"10.1016\/j.nano.2021.102417_bb0230","article-title":"Formation of nanoparticles in aqueous solution from poly (\u03b5-caprolactone)\u2013poly (ethylene glycol)\u2013poly (\u03b5-caprolactone)","volume":"1","author":"Nguyen","year":"2010","journal-title":"Adv Nat Sci Nanosci Nanotechnol"},{"issue":"36","key":"10.1016\/j.nano.2021.102417_bb0235","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.2174\/138161206779026245","article-title":"Polymeric micelles for drug delivery","volume":"12","author":"Croy","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.nano.2021.102417_bb0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"2","key":"10.1016\/j.nano.2021.102417_bb0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.amjhyper.2003.09.008","article-title":"Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients","volume":"17","author":"Eguchi","year":"2004","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1016\/j.nano.2021.102417_bb0250","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/00004872-199012000-00003","article-title":"Prediction of the antihypertensive response to enalapril","volume":"8","author":"Meredith","year":"1990","journal-title":"J Hypertens"},{"issue":"22","key":"10.1016\/j.nano.2021.102417_bb0255","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.1989.03420220087032","article-title":"How often is medication taken as prescribed? A novel assessment technique","volume":"261","author":"Cramer","year":"1989","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.nano.2021.102417_bb0260","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ajh.2010.217","article-title":"Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications","volume":"24","author":"Hermida","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.nano.2021.102417_bb0265","doi-asserted-by":"crossref","unstructured":"Hermida RC, Smolensky MH. Chronotherapy of hypertension. Current opinion in nephrology and hypertension. 2004;13(5).","DOI":"10.1097\/00041552-200409000-00004"},{"key":"10.1016\/j.nano.2021.102417_bb0270","doi-asserted-by":"crossref","unstructured":"Pons-Faudoa FP, Sizovs A, Shelton KA, Momin Z, Niles JA, Bushman LR, Xu J, Chua CYX, Nichols JE, Demaria S, Ittmann MM, Hawkins T, Rooney JF, Marzinke MA, Kimata JT, Anderson PL, Nehete PN, Arduino RC, Ferrari M, Sastry KJ, Grattoni A. Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates. Advanced Therapeutics. 2020;n\/a(n\/a):2000163.","DOI":"10.1101\/2020.05.13.091694"},{"key":"10.1016\/j.nano.2021.102417_bb0275","unstructured":"Bruno G, Canavese G, Liu X, Filgueira CS, Sacco A, Ferrari M, Grattoni A. Active modulation of drug release by ionic field effect transistor for an ultra-low power implantable nanofluidic system.9."},{"issue":"13","key":"10.1016\/j.nano.2021.102417_bb0280","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1039\/C9LC00394K","article-title":"Remotely controlled nanofluidic implantable platform for tunable drug delivery","volume":"19","author":"Di Trani","year":"2019","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.nano.2021.102417_bb0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199222010-00003","article-title":"Clinical pharmacokinetics of amlodipine","volume":"22","author":"Meredith","year":"1992","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"10.1016\/j.nano.2021.102417_bb0290","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00044011-200525100-00006","article-title":"Simulated fluctuations in plasma drug concentrations for patients receiving oxcarbazepine or carbamazepine extended-release capsules","volume":"25","author":"Ahmad","year":"2005","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.nano.2021.102417_bb0295","doi-asserted-by":"crossref","first-page":"340315","DOI":"10.1155\/2013\/340315","article-title":"Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs","volume":"2013","author":"Xu","year":"2013","journal-title":"Journal of Drug Delivery"},{"issue":"2","key":"10.1016\/j.nano.2021.102417_bb0300","first-page":"153","article-title":"Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone","volume":"21","author":"Alami-Milani","year":"2018","journal-title":"Iran J Basic Med Sci"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:17:13Z","timestamp":1761549433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":60,"alternative-id":["S1549963421000605"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102417","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting tunable release of amlodipine loaded PEG-PCL micelles for tailored treatment of chronic hypertension","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102417"}}